Pravin Anand and Safir Anand have been recognised for the second time as the “elite of the trademark world” by WTR Global Leaders 2020. WTR Global Leaders brings
The IPAB allowed an appeal and granted a patent to Pfizer for Tofacitinib and its salts (application 991/MUMNP/2003). an appeal and granted a patent to Pfizer for its
While some flaws remain, the many advantages of virtual courts mean they should become a part of how cases are heard when normalcy returns, writes Pravin Anand. The
By Arpita Kulshrestha. Amidst the widespread awareness for protecting inventions and securing robust patents, it is pertinent that a Patent Applicant is also aware that the rejection of
By Ritika Ahuja and Jasbir Singh. Artificial Intelligence, a fuel to almost every industry today, has shown a paradigm shift in technology over a period of time and
Managing Partner Pravin Anand has been recognised as “Litigation Star – Asia Pacific 2020” by the prestigious Benchmark Litigation while ANAND AND ANAND continue to be ranked the
By Vaishali Mittal and Siddhanth Chamola. The IP litigation landscape has changed dramatically in the past decade with businesses becoming more technology-driven and technology-dependent than ever before. Innovation
By Nupur Maithani. Stem cells offer hope as a promising treatment option for various diseases and are the future of medicine. Embryonic stem cells, have been at the
By Tusha Malhotra and Pankhuri Malik. In 2018, in the case of Swapnil Tripathi v Supreme Court of India, the Supreme Court of India had advised that it was
Mr. Pravin Anand and Ridhie Bajaj argue in favour of fixed time slots for arguments and for leading evidence in IP litigation before Indian Courts. The Commercial Courts Act 2015 has reduced the life
